Status | Study |
Recruiting |
Study Name: Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan Condition: Type 2 Diabetic Nephropathy Date: 2017-04-06 Interventions: Drug: Alfacalcidol Other Name: |
Recruiting |
Study Name: Resveratrol's Effects in Diabetic Nephropathy Condition: Diabetic Nephropathy Date: 2016-03-04 Interventions: Drug: Resveratrol Resveratrol |
Completed |
Study Name: Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy Condition: Diabetic Nephropathy Date: 2015-08-04 Interventions: Drug: MT-3995 Low Drug: MT-3995 Middle |
Recruiting |
Study Name: Colchicine for Diabetic Nephropathy Trial Condition: Diabetic Nephropathies Date: 2015-04-30 Interventions: Drug: Colchicine up to 2mg of |
Completed |
Study Name: Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy Condition: Diabetic Nephropathy Date: 2014-07-27 Interventions: Drug: MT-3995 Drug: Placebo |
Completed |
Study Name: The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy Condition: Diabetic Nephropathy Date: 2014-07-23 |
Completed |
Study Name: Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy Condition: Diabetic Nephropathy Date: 2013-06-26 Interventions: Drug: MT-3995-Low Drug: MT-3995-High |
Recruiting |
Study Name: Study Of Diabetic Nephropathy With Atrasentan Condition: Diabetic Nephropathy Date: 2013-05-17 Interventions: Drug: Atrasentan Oral daily lo |
Completed |
Study Name: Minocycline and Proteinuria in Diabetic Nephropathy Condition: Diabetic Nephropathy Date: 2013-01-28 Interventions: Drug: Minocycline 100 mg po bid for 6 months |
Completed |
Study Name: A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria Condition: Diabetic Nephropathy Date: 2012-12-20 Interventions: Drug: MT-3995 Low MT-3995 Low |